Enhancements to Augury’s AI-based machine health platform include new capabilities and collaboration tools for personnel working remotely.
Augury, which supplies AI-based machine health solutions, launched new capabilities and enhancements for remote monitoring and diagnosis of manufacturing equipment, including pharmaceutical manufacturing. A new feature called Augury Threads is a collaboration tool that allows maintenance teams, reliability experts, and operations teams to share analytics, insights, recommendations, and actions about critical machines from anywhere in the world.
Other improvements to the Augury platform include remote diagnostics, such as improved machine health and anomaly-based alerts, with deeper root cause analysis and prescriptive maintenance recommendations. The company has enhanced remote feedback and troubleshooting with improvements to the speed and functionality of diagnostic feedback on repairs. According to the press release, maintenance actions can be validated in near-real time by logging a repair and initiating a conversation with an Augury machine health expert. The platform offers a remote view of machine history, which can be combined with the new Augury Threads feature as a single place to track the history of a machine’s performance and the expert reliability conversations around it. The new Augury Threads feature is available now to Augury customers using Halo sensors, and all other features are available to all Augury customers, said the company in a March 23, 2020 press release. The company is also providing increased support for remote on-boarding of new personnel and machines.
Source: Augury
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.